NextCYTE Breast Cancer Test

The NextCYTE Breast Cancer Test uses genomic analysis to provide important insights to inform and improve the effectiveness of breast cancer treatment for women with early-stage breast cancer. The NextCYTE test will offer the next generation of genomic evaluation of risk for recurrent breast cancer and therapy selection, evaluating more genes for more informed patient management. In pre-validation, academic testing the larger gene activity database of the NextCYTE test provided superior clinical predictive outcomes data compared to first generation gene activity profiles. The NextCYTE test report indicates the risk of cancer recurrence and provides a personal profile that helps women and their caregivers determine the best course of treatment to restore breast health.

Overview

The NextCYTE test will be available in the fall/2012 to spring/2013

Specimen

Details on specimen collection will be provided as the NextCYTE test becomes available.

Clinical and Interpretive

Details on the clinical and interpretive data will be provided as the NextCYTE test becomes available.

Performance

Details on the performance of the test will be provided as the NextCYTE test becomes available.

Coding

Details on coding will be provided as the NextCYTE test becomes available.